• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
CSII

CSII

Cardiovascular Systems, Inc.

NASDAQHealthcareMedical - DevicesUS

USD20.00

+0.03 (+0.15%)

Company Profile

CEO

Scott Raymond Ward MS

IPO Date

2006-06-28

Sector

Healthcare

Industry

Medical - Devices

Exchange

NASDAQ

Country

US

Market Metrics

Open

$19.99

Prev. Close

$19.97

Day Low

$19.98

Day High

$20.00

52W Low

$12.26

52W High

$20.00

Market Cap

$0.84B

Volume

0.39M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

32.5%

Avg Negative

13.1%

Avg Neutral

54.5%

News Feed

First Patients in Canada Treated With Cardiovascular Systems, Inc. Diamondback 360® Coronary Orbital Atherectomy System

Business Wire·8/30/2021·↑ positive

Cardiovascular Systems' (CSII) CEO Scott Ward on Q4 2021 Results - Earnings Call Transcript

Seeking Alpha·8/8/2021·↓ negative

Cardiovascular Systems, Inc. to Attend Three Investor Conferences in August

Business Wire
·7/27/2021
·↑ positive

Cardiovascular Systems stock drops after CMS proposes payment cuts, but Needham says buy on weakness

Market Watch·7/15/2021·↓ negative

Cardiovascular Systems (CSII) Coronary Arm Grows, Margin Dips

Zacks Investment Research·5/21/2021·↑ positive

Cardiovascular Systems (CSII) Coronary OAS Study Data Favorable

Zacks Investment Research·5/21/2021·↑ positive

New Study Demonstrates Exceptional Performance With Cardiovascular Systems' Diamondback 360® Coronary Orbital Atherectomy System (OAS) Dual Mode of Action

Business Wire·5/20/2021·↑ positive

Cardiovascular Systems (CSII) Q3 Loss Widens, Gross Margin Dips

Zacks Investment Research·5/11/2021·↑ positive

Cardiovascular Systems, Inc. (CSII) CEO Scott Ward on Q3 2021 Results - Earnings Call Transcript

Seeking Alpha·5/9/2021·↓ negative

Cardiovascular Systems (CSII) Reports Q3 Loss, Misses Revenue Estimates

Zacks Investment Research·5/6/2021·↑ positive